ライフサイエンスコーパス: elevated BP

1 ce in the prior 24 months and had at least 2 elevated BP measurements (>150/90 mm Hg or >140/90 mm Hg

2 patients used text messaging, had at least 2 elevated BP measurements during the prior 24 months, and

3 EHR inbox when patients submitted at least 3 elevated BP readings.

4 intensified medications in 30% of the 68,610 elevated BP events, with almost no variation in intensif

5 l protein, TGFBR3, which may protect against elevated BP and long-term CVD outcomes.

6 ow up for visits during the 4 weeks after an elevated BP measurement.

7 of days to the next scheduled visit after an elevated BP measurement.

8 ment-resistant hypertension is defined as an elevated BP despite the use of >=3 antihypertensive medi

9 one third of visits in which patients had an elevated BP.

10 ility in BP, tracking is weak, and having an elevated BP in childhood has a low predictive value for

11 ss 27 studies, 35% to 95% of persons with an elevated BP at screening remained hypertensive after non

12 aged 20 years or older with hypertension and elevated BP (defined as an SBP level >=140 mm Hg) during

13 othesized that black race, malnutrition, and elevated BP would be associated with the risk of stroke

14 lood pressure (BP) in the clinic setting and elevated BP assessed by ambulatory monitoring, is associ

15 ased chromaffin granule size and number; (b) elevated BP; (c) loss of diurnal BP variation; (d) incre

16 95 of 934 participants (53.0%) with baseline elevated BP, 673 of 966 (69.7%) with baseline stage 1 hy

17 udy examines whether the association between elevated BP and AMI risk differs by HIV status.

18 ersisted after adjusting for age, sex, BMIZ, elevated BP, and hypercholesterolemia (RR, 1.43; P = .02

19 Childhood elevated BP was defined according to the tables from the

20 resistant to developing albuminuria despite elevated BP.

21 % to 33%) increase in the odds of developing elevated BP during follow-up, with higher adjusted odds

22 fying children who are at risk of developing elevated BP.

23 mal burst frequency result in normal or even elevated BP in POTS patients.

24 Haplotype *4 carriers exhibited elevated BP and fat mass, haplotype *6 was associated wi

25 cardiovascular diagnoses and who experienced elevated BPs in the first 48 hours of hospitalization.

26 The 8-week MB-BP program was adapted for elevated BP, including personalized feedback, education,

27 These findings suggest that EHR alerts for elevated BP during remote monitoring were effective in p

28 e more likely than those without AKI to have elevated BP--defined as documented BP>140/90 mmHg measur

29 tion directed at patients in the ED who have elevated BP was associated with greater reduction in SBP

30 ldhood has a low predictive value for having elevated BP later in life.

31 antihypertensive medication, and not having elevated BP, respectively.

32 This risk was reduced if elevated BP during childhood resolved by adulthood.

33 Differences in elevated BP (EBP) prevalence among centers at years 0, 2

34 l-specific Heg1 deletion in mice resulted in elevated BP, impaired endothelium-dependent vasodilation

35 ations in several markers of MetS, including elevated BP, increased glucose concentrations, and reduc

36 rexpression during pregnancy in mice induced elevated BP and glomerular endotheliosis, which resolved

37 emale, Ift88 KO mice had polycystic kidneys, elevated BP, and reduced urinary NOx excretion.

38 oefficient (odds ratio [OR]) for maintaining elevated BP/hypertension was 2.16 (95% CI, 1.95-2.39).

39 rs a low-cost targeted strategy for managing elevated BP in this genetically at-risk group.

40 ate analyses accounted for the clustering of elevated BP events within patients and adjusted for pati

41 nt risk factor for subsequent development of elevated BP.

42 EMR entry of elevated BP (systolic BP >=140 mm Hg or diastolic BP >=9

43 The contemporary approach to the epidemic of elevated BP and its complications involves pharmacologic

44 For each episode of elevated BP during 2005 (68,610 events), we used electro

45 sposes to the metabolic syndrome features of elevated BP, fat mass or TG level, therefore appearing m

46 aluate how to simplify the identification of elevated BP, to evaluate the long-term benefits and harm

47 significantly associated with higher odds of elevated BP levels: It led to a 26, 30, and 77% higher r

48 used to examine the temporal relationship of elevated BP to arterial stiffness and elasticity.

49 Rescue of elevated BP to normalcy was achieved by either exogenous

50 ividuals with HTN at a lower genetic risk of elevated BP experienced an approximately 3.5 mm Hg-great

51 ith those at an intermediate genetic risk of elevated BP.

52 Family-based mapping studies of elevated BP cover the large intermediate ground for iden

53 ch in clinical practice for the treatment of elevated BP in persons with CKD is to achieve a BP less

54 reports, have recognized the high impact of elevated BPs and influenced lower BPs with subsequent st

55 d CIH rats partially reversed EA's effect on elevated BP (n = 4).

56 ed more than 500 adults with hypertension or elevated BP and that were 6 months or longer in duration

57 strongly associated with concurrent and past elevated BP with the population burden of severe WMH gre

58 Persistently elevated BP prompted a second interruptive clinician-fac

59 Individuals with persistently elevated BP and individuals with normal childhood BP, bu

60 Individuals with persistently elevated BP from childhood to adulthood had increased ri

61 8]) in compared with those with persistently elevated BP.

62 nosis by a clinician) relative to the second elevated BP measurement was categorized as (1) preexisti

63 This variability, alongside evidence that elevated BP is often not acted on during clinic visits,

64 These findings provide strong evidence that elevated BP precedes large-artery stiffening in middle-a

65 lar filtration, reduced proteinuria, and the elevated BP, and it had no effect on PAN-induced increas

66 The optimal BP and the component of the elevated BP that affect the risk have not been defined.

67 sive rat (SHR) which could contribute to the elevated BP.

68 ble and lifestyle risk factors contribute to elevated BP levels.

69 se three genes are important contributors to elevated BP in the population at large.

70 Long-term exposure to elevated BP across its whole spectrum is associated with

71 th the magnitude and duration of exposure to elevated BP over time.

72 vealed that NG(AT1aR) couple their firing to elevated BP, induced by phenylephrine (i.v.).

73 dverse clinical outcomes that are related to elevated BP?

74 0 y; BMI (in kg/m(2)): 25-35] with untreated elevated BP (BP >/=130/85 and <160/100 mm Hg) were rando

75 ts were similar in sensitivity analyses when elevated BP was defined as having at least two BP readin

76 on and treatment decisions among adults with elevated BP and hypertension is unclear.

77 The results indicate that adults with elevated BP may effectively incorporate lean pork into a

78 S: This cohort study enrolled US adults with elevated BP or hypertension between January 1, 2015, and

79 upport DASH dietary adherence in adults with elevated BP.

80 cardiometabolic risk factors for adults with elevated BP; thus, improved payment for and access to MN

81 ive net worth (ie, debt) was associated with elevated BP in African American women, independent of tr

82 k of cardiovascular diseases associated with elevated BP in childhood, to evaluate how to simplify th

83 It is closely associated with elevated BP.

84 P) and prevent complications associated with elevated BP.

85 n adults without diagnosed hypertension with elevated BP recruited from 12 primary care clinics of an

86 In contrast, individuals with elevated BP as children but not as adults did not have s

87 nin T or NT-proBNP identify individuals with elevated BP or hypertension not currently recommended fo

88 gy, can increase linkage of individuals with elevated BP to a hypertension care program in western Ke

89 The relationship of OH with elevated BP, but not antihypertensive medication use, su

90 Participants with elevated BP or hypertension not recommended for antihype

91 Among participants with elevated BP recruited from an urban safety-net Emergency

92 address hypertension in 38% of patients with elevated BP in the clinic.

93 People with elevated BP are at increased risk of diabetes.

94 Whether HIV-infected people with elevated BP have excess AMI risk compared to uninfected

95 At first presentation with elevated BP, gestational hypertension was most common di

96 eafy green vegetables on BP in subjects with elevated BP, with the aim of elucidating if any such eff

97 not decrease ambulatory SBP in subjects with elevated BP.

98 with the low-stable group, trajectories with elevated BP levels had greater odds of having a CAC scor

99 pressure (BP) control in men and women with elevated BP.

100 te that among hospitalized older adults with elevated BPs, intensive pharmacologic antihypertensive t